PenderFund Capital Management »

Cerevel Therapeutics Hldng I shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $962k 17k 57.26
2023-12-31 $528k 9.4k 56.18

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Novavax Note 5.000%12/1 Added (Principal)
Burford Cap Ord Shs (BUR)
PAR Technology Corporation (PAR)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Cable One Note 1.125% 3/1 (Principal)
Docebo (DCBO)
Aviat Networks Com New (AVNW)
Nuveen Insured Tax-Free Adv Munici (NEA)

View all positions for PenderFund Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Fil
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
Citigroup
Geode Capital Management
FMR
Baker Bros. Advisors
Millennium Management

View all funds holding Cerevel Therapeutics Hldng I